The Discounted Cash Flow (DCF) valuation of Surgery Partners Inc (SGRY) is 20.98 USD. With the latest stock price at 14.23 USD, the upside of Surgery Partners Inc based on DCF is 47.4%.
Based on the latest price of 14.23 USD and our DCF valuation, Surgery Partners Inc (SGRY) is a buy. buying SGRY stocks now will result in a potential gain of 47.4%.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 8.3% | 7.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 11.68 - 37.57 | 20.98 |
| Upside | -17.9% - 164.0% | 47.4% |